NARA Discovery
Article Details
← Back to Search Results
Journal Article

Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence

Luis Angel Monsalvo-Maraver; Enid A. Ovalle-Noguez; Jade Nava-Osorio; Marisol Maya-López; Edgar Rangel-López; Isaac Túnez; Alexey A. Tinkov; Yousef Tizabi; Michael Aschner; Abel Santamaría; Diana C. Medrano-Cruz; Uriel García-Flores; Sara I. Castañeda-Roque; Dan L. Romero-Méndez; Elizabeth Varillas-Galicia; Daniela Rojas-Lobato; Santiago Navas-Escobar; Karen Rentería-Pérez
Neurotoxicity Research · Vol. 42, Issue 2 · 2024

Abstract

Neurodegenerative disorders are chronic brain diseases that affect humans worldwide. Although many different factors are thought to be involved in the pathogenesis of these disorders, alterations in several key elements such as the ubiquitin–proteasome system (UPS), the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway, and the endocannabinoid system (ECS or endocannabinoidome) have been implicated in their etiology. Impairment of these elements has been linked to the origin and progression of neurodegenerative disorders, while their potentiation is thought to promote neuronal survival and overall neuroprotection, as proved with several experimental models. These key neuroprotective pathways can interact and indirectly activate each other. In this review, we summarize the neuroprotective potential of the UPS, ECS, and Nrf2 signaling, both separately and combined, pinpointing their role as a potential therapeutic approach against several hallmarks of neurodegeneration. Graphical Abstract

Bibliographic Information

JournalNeurotoxicity Research
PublisherSpringer
Publication Date2024-04-01
Publication Year2024
Volume42
Issue2
Document TypeJournal Article
Print ISSN1029-8428
eISSN1476-3524
DOI10.1007/s12640-024-00694-3

Access Information

NARA Access Coverage1999-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12640
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.